Lung function in operated lung after lobectomy.
نویسندگان
چکیده
منابع مشابه
Effects of lobectomy on lung function.
The effect of lobectomy on lung function was investigated in 16 patients in whom comprehensive lung function tests were performed before and between six weeks and six months after lobectomy. The operation was well tolerated even by patients with quite severe airways obstruction. The effect of lobectomy on forced flow rates was in keeping with the change in lung volumes. There was no alteration ...
متن کاملLobectomy for metachronous lung cancer after pneumonectomy.
Second primary non-small cell lung cancer (NSCLC) is a well-known disease in patients having undergone successful NSCLC resection. Surgery for patients with cancer in the residual lung after pneumonectomy should not be excluded automatically. However, surgery on a single residual lung is usually done by wedge resection or segmentectomy, whereas lobectomy remains somewhat exceptional. We report ...
متن کاملImprovement of pulmonary function after lobectomy for non-small cell lung cancer in emphysematous patients.
OBJECTIVE Pulmonary emphysema is frequently associated with lung cancer and, because of the impaired pulmonary function involved, it may contraindicate surgical treatment. However, improvement of pulmonary function has been observed after surgical resection in patients with advanced emphysema. The aim of this study was to evaluate whether pulmonary emphysema, as assessed by pulmonary function t...
متن کاملPulmonary Function Changes Over 1 Year After Lobectomy in Lung Cancer.
BACKGROUND This study was conducted to measure the serial changes in pulmonary function over 12 months after lobectomy in subjects with lung cancer and to evaluate the actual recovery of pulmonary function in comparison with the predicted postoperative values. METHODS Subjects who underwent lobectomy for primary lung cancer were included in this study. In the statistical analysis, we included...
متن کاملEffects of sirolimus on Lung function in patients with Lymphangioleiomyomatosis
Background: Lymphangioleiomyomatosis (LAM) is a progressive lungs disease that affects women at reproductive years. Sirolimus inhibits mammalian target of rapamycin (mTOR) and its administration in past studies was hopeful in treatment of patients with LAM. The aim of this study was to evaluate sirolimus therapy on lung function in LAM patients. Methods: We conducted a trial to evaluate the ef...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of the Japanese Association for Chest Surgery
سال: 1991
ISSN: 0917-4141,1884-1724
DOI: 10.2995/jacsurg1987.5.619